Kalp Cerrahisinde Hemorajik ve Trombotik Komplikasyonlar

Service des Etudes. Indication des examens preopera- toires. Paris: Agence Nationale pour le Developpement de I’evaluation Medicale, 1992.

Tamiya T, Yamasaki M, et al. Complement activation in cardiopulmonary bypass with special reference to anaphylatoxin production in membrane and bubble oxygenators. Ann Thorac Surg, 1988;46:47.

Despotis GJ, Santaro SA, Spitznagel E et al. Prospec- tive evaluation and clinical utility of on-site monitoring of coagulation in patients undergoing cardiac operati- on. J Thorac Cardiovasc Surg, 1994;107:271-9.

Kalter RD, Saul CM, Wetstein L, Soriano C, Reiss RF. Car- diopulmonary bypass. Associated hemostatic abnor- malities. J Thorac Cardiovasc Surg, 1979;77:427-35.

Heimark RL, Kurachi K, Fujikawa K, Davie EW. Sur- face activation of blood coagulation, fibrinolysis and kinin formation. Nature, 1980;286:456-60.

Boisclair MD, Lane DA, Philippou H et al. Mechanisms of trombin generation during surgery and cardiopul- monary bypass. Blood, 1993;82:3350-7.

De Haan J, Boonstra PW, Monnink SH, Ebels T, Van Oeveren W. Retransfusion of suctioned blood during cardiopulmonary bypass impairs hemostasis. Ann Thorac Surg, 1995;59:901-7.

Tabuchi N, De Haan J, Boonstra PW, Van Oeveren W. Activation of fibrinolysis in the pericardial cavity during cardiopulmonary bypass. J Thorac Cardiovasc Surg, 1993;106:828-33.

Gram J, Janetzko T, Jespersen J, Bruhn HD. Enhanced effective fibrinolysis following the neutralization of heparin in open heart surgery increases the risk of post-surgical bleeding. Thromb Haemost, 1990;63:241.

Edmunds LH Jr, Ellison N, Colman RW et al. Platelet function during open heart surgery: Comparison of the membrane and bubble oxygenators. J Thorac Cardiovasc Surg, 1982;83:805.

Zilla P, Fasol R, Groscurth P et al. Blood platelets in cardiopulmonary bypass operations. J Thorac Cardiovasc Surg, 1989;97:379.

Cramer EM, Lu H, Caen JP et al. Differential redistribu- tion opf platelet glycoproteins Ib and Iıb-IIIa after plas- min stimulation. Blood, 1991;77:694-9.

Coughlin SR, Vu T-KH, Hung DT, Wheaton VI. Charac- terization of a functional thrombin receptor. J Clin Invest, 1992;89:351.

Khuri SF, Valeri CR, Loscalzo J et al. Heparin causes platelet dysfunction and induces fibrinolysis before cardiopulmonary bypass. Ann Thorac Surg, 1995;60: 1008.

Rinder CS, Rinder HM, Smith BR et al. Blockade of C5a and C5b-9 generation inhibits leukocyte and pla- telet activation during extracorporeal circulation. J Clin Invest, 1995;96:1564.

Valeri CR, Khabbaz K, Khuri SF et al. Effect of skin temperature on platelet function in patients undergo- ing extracorporeal bypass. J Thorac Cardiovasc Surg, 1992;104:108.

Czer LSC, Bateman TM, Gray RJ et al. Treatment of severe platelet dysfunction and hemorrhage after car- diopulmonary bypass: reduction in blood product usage with desmopressin. J Am Coll Cardiol, 1987;9:1139-47.

Michelson EL, Torosian M, Morganroth J, MacVaugh H III. Early recognition of surgically correctable causes of excessive mediastinal bleeding after coronary ar- tery bypass graft surgery. Am J Surg, 1980;139:313-7.

Verska JJ, Lonser ER, Brewer LA III. Predisposing fac- tors and management of hemorehage following open heart surgery. J Cardiovasc Surg, 1972;13:361-8.

Czer LSC. Mediastinal bleeding after cardiac surgery: Etiologies, diagnostic considerations, and blood con- versation methods. J Cardiothorac Anesth, 1989;3:760-5.

Hartstein G, Janssens M. Treatment of excessive mediastinal bleeding after cardiopulmonary bypass. Ann Thorac Surg, 1996;62:1951-4.

Edmund LH Jr. Pulseless cardiopulmonary bypass. J Thorac Cardiovasc Surg, 1982;84:800.

Boucher JK, Rudy LW, Edmunds LH Jr. Organ blood flow during cardiopulmonary bypass. J Appl Physiol, 1974;36:86.

Tominaga R, Smith WA, Massiello A et al. Chronic nonpulsatile blood flow. Cerebral autoregulation imn chronic nonpulsatile biventricular bypass: carotid blood flow response to hypercapnia. J Thorac Cardiovasc Surg, 1994;108:907.

Rudy LW Jr, Heymann MA, Edmunds LH Jr. Distribution of systemic blood flow during cardiopul- monary bypass. J Appl Physiol, 1973;34:194.

Harker LA, Malpass TW, Branson HE et al. Mecha- nism of abnormal bleeding in patients undegoing car- diopulmonary bypass: Acquired transient platelet dysfunction associated with selective alpha granule release. Blood, 1980;56:284.

Kelton JG, Smith JW, Warkentin TE et al. Immunoglo- bulin G from patients with heparin-induced throm- bocytopenia binds to a complex of heparin and plate- let factor 4. Blood, 1994;83:3232.

Bell WR. Heparin-associated thrombocytopenia and thrombosis. J Lab Clin Med, 1988;111:600.

Shulman NR, Reid DM. Platelet immunology in Colman RW, Hirsh J, Marder VJ, Salzman EW (eds): Hemostasis and Thrombosis Basic Principles and Clinical Practice. Philadelphia, Lippincott, 1994;p:414.

Luddington RJ. Thromboelastography/ Thromboelastometry. Clin Lab Haematol. 2005 Apr;27(2):81-90.

Redfern RE, Fleming K, March RL, et al. Thrombelastography-Directed Transfusion in Cardiac Surgery: Impact on Postoperative Outcomes. Ann Thorac Surg. 2019 May;107(5):1313-1318

Ak K, Atalan N, Tekeli A, Işbir S, Civelek A, Emekli N, Arsan S. Thromboelastography and its use in cardiac surgery. Anadolu Kardiyol Derg. 2008 Apr;8(2):154-62.

Akan M. Erişkin karaciğer transplantasyonunda yoğun bakım yönetimi. J Turk Soc Intensive care, 2017;15:1-20.

Kern FH, Morana NJ, Sears JJ, Hickey PR. Coagulation defects in neonates during cardiopulmo- nary bypass. Ann Thorac Surg, 1992;54:541-6.

Andrew M, Paes B, Milner R, et al. Development of the human coagulation system in the full-term infant. Blood, 1987;70:165-72.

Guay J, Rivard GE. Mediastinal bleeding after cardio- pulmonary bypass in pediatric patients. Ann Thorac Surg, 1996;62:1955-60.

Maurer HM, McCue CM, Caul J, Still WJS. Impair- ment in platelet aggregation in conjenital heart disea- se. Blood, 1972;40:207-16.

Dietrich W, Mössinger H, Spannagl M et al. Hemos- tatic activation during cardiopulmonary bypass with different aprotinin dosages in pediatric patients having cardiac operations. J Thorac Cardiovasc Surg, 1993;105:712-20.

Lisi G, Sani G, Maccherini M, Biagioli B, Toscano M. Platelet function and hypothermic cardiopulmonary bypass. Ann Thorac Surg, 1993;56:1442-3.

Khuri SF, Wolfe JA, Josa M et al. Hematologic chan- ges during and after cardiopulmonary bypass and their relationship to the bleeding time and nonsurgi- cal blood loss. J Thorac Cardiovasc Surg, 1992;104:94- 107.

Ilabaca PA, Ochsner JL, Mills NL. Positive end-expira- tory pressure in the management of the patient with a postoperative bleeding heart. Ann Thorac Surg,1980; 30:281-4.

Gray RJ, Bateman TM, Czer LSC, Conklin C, Matloff JM. Use of esmolol in hypertension after cardiac sur- gery. Am J Cardiol, 1985;56:49-56.

Rodgers RPC, Levin J. A criticial reappraisal of the bleeding time. Semin Throm Hemost, 1990;16:1-20.

Uehlinger J, Adedort LM. Blood product usage in car- diac surgery. J Cardiothorac Anesth, 1989;3:776-84.

Mannucci PM. Desmopressin (DDAVP) for treatment disorders of hemostasis. Prog Hemost Throm, 1986;8:19-45.

Sloand EM, Alyono D, Klein HG et al. 1-Deamino-8-D- arginine vasopressin (DDAVP) increases platelet membrane expression of glycoprotein Ib in patients with disorders of platelet function and after cardiopul- monary bypass. Am J Hematol, 1994;46:199-207.

Vander Salm TJ, Ansell JE, Okike ON et al. The role of epsilon- amincaproic acid in reducing bleeding after cardiac operation: A double-blind randomized study. J Cardiovasc Surg, 1988;95:538-40.

Daily PO, Lamphere JA, Dembitsky WP, Adamson RM, Dans NF. Effect of prophylactic epsilon-amincaproic acid on blood loss and transfusion requirements in patients undergoing first time coronary artery bypass grafting. A randomized, prospective, double-blind study. J Thorac Cardiovasc Surg,1994;108:99-108.

DelRossi AJ, Cernaianu AC, Botros AC, Lemole GM, Moore R. Prophylactic treatment of postperfusion bleeding using EACA. Chest, 1989;96:27-30.

Janssens M, Harstein G, David JL. Reduction in requi- rements for allogeneic blood products: Pharmaco- logic methods. Ann Thorac Surg, 1996;62:1944-50.

Arom KV, Emery RW. Decreased postoperative draina- ge with addition of Î-aminocaproic acid before cardio- pulmonary bypass. Ann Thorac Surg, 1994;57:1108-13.

Karski JM, Teasdale SJ, Norman PH et al. Prevention of postbypass bleeding with tranexamic acid and epsi- lon-aminocaproic acid. J Cardiothorac Vasc Anesth, 1993;7:431-5.

Levy JH. Pharmacologic preservation of the hemosta- tic system during cardiac surgery. Ann Thorac Surg, 2001;72:1814-20.

Landis RC, Haskard DO, Taylor KM. New antiinflam- matory and platelet-preserving effects of aprotinin. Ann Thorac Surg, 2001;72:1808-13.

Vander Salm TJ, Ansell JE, Okike ON et al. The role of epsilon-aminocaproic acid in reducing bleeding after cardiac operation: A double-blind randomized study. J Thorac Cardiovasc Surg, 1988;95:538.

Royston D. High dose aprotinin therapy: A review of the first five years experience. J Cardiothorac Vasc Anesth, 1992;6:76.

Cosgrove DM III, Heric B, Lytle BW et al. Aprotinin the- rapy for reoperative myocardial revascularization: A placebo-controlled study (discussion). Ann Thorac Surg, 1992;54:1031.

Sundt TM III, Kouchoukos NT, Saffitz JE et al. Renal dysfunction and intravascular coagulation with aproti- nin and hypothermic circulatory arrest. Ann Thorac Surg, 1993;55:1418.

Laub GW, Riebman JB, Anderson WA et al. The impact of aprotinin on coronary artery bypass graft patency. Chest, 1994;106:1370.

Dennis MF. Anticoagulation monitoring during cardi- ac surgery. Anesthesiology, 1999;91:1122-52

Blauth CI, Smith PL, Arnold JV et al. Influence of oxy- genator type on the prevalence and extend of micro- embolic retinal ischemia during cardiopulmonary bypass. J Thorac Cardiovasc Surg, 1990;99:61.

Clark RE, Magraf HW, Beauchamp RA. Fat and solid filtration in clinical perfusion. Surgery, 1975;77:216.